2023年國際 SCI 論文
| 編號 | 篇名 | 作者 | 期刊 | 卷期 |
| 1 | Evaluation of the timing of using direct oral anticoagulants after ischemic stroke for patients with atrial fibrillation |
Yu HT, Chen KH, Lin CJ, Hsu CC, Chang YL | Heliyon | 2023;9(3):e14456 |
| 2 | Hypoglycemia risk with inappropriate dosing of glucose-lowering drugs in patients with chronic kidney disease: a retrospective cohort study | Li YJ, Chang YL, Chou YC, Hsu CC | Sci Rep | 2023;13(1):6373 |
| 3 | A retrospective cohort study on the cardiotoxicity incidence rates of immune checkpoint inhibitors for oncology patients | Ho CC, Wu SL, Tsai HY, Hu YW, Chang YL | J Chin Med Assoc | 2023; 86(5):499-505 |
| 4 | The Clinical Benefits of Antiresorptive Agents in Primary Breast Cancer Patients Receiving Adjuvant Endocrine Therapy: A Systematic Review with Pairwise and Network Meta-analysis | Wang SF, Lin YS, Yeh WY, Chang YL, Chiang CE, Chen CH, Tseng LM, Lee HC, Liu CY, Cheng HM | J Clin Endocrinol Metab | 2023 May 12. Online ahead of print |
| 5 | Growth differentiation factor 15 induces cisplatin resistance through upregulation of xCT expression and glutathione synthesis in gastric cancer | Wang SF, Chang YL, Fang Wl, Li AFY, Chen CF, Yeh TS, Hung GY, Huang KH, Lee HC | Cancer Sci | 2023; 114(8):3301-3317 |
| 6 | Effect of co-medications and potential risk factors of high-dose methotrexate-mediated acute hepatotoxicity in patients with osteosarcoma | Wang SF, Huang KW, Chou YC, Lee HC, Wu PK, Chen WM, Hung GY, Chang YL | Cancer Med | 2023;12(11):12354-64 |
| 7 | Effectiveness and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and advanced kidney disease | Hsu CC, Chen CC, Chou CY, Chen KH, Wang SF, Chang SL, Chang YL | J Thromb Thrombolysis | 2023 Jul 15. Online ahead of print |
| 8 | Role of mitochondrial alterations in human cancer progression and cancer immunity | Wang SF, Tseng LM, Lee HC | J Biomed Sci | 2023;30(1)61 |
最後更新：